JP Morgan Initiates Coverage of Neurogene at Overweight
Fintel reports that on October 8, 2026, JP Morgan initiated coverage of Neurogene (NASDAQGM:NGNE) (DB:UU8) with a Overweight recommendation.
Prior to this rating action, the stock closed at $25.87 on October 7, 2026. This latest close represents a price change of -7.01% over one week, relative to a baseline close of $27.82 on September 30, 2026. Over a one-month period, the stock experienced a price change of -32.98% from its baseline close of $38.60 on September 4, 2026.
As of October 2, 2026, the current consensus target mean for the stock was $82.04, which is unchanged from the prior consensus target mean of $82.04 recorded on September 16, 2026, representing a consensus target revision of 0.00%. The current consensus target median was $66.30 as of October 2, 2026, reflecting an implied change of +217.11%.
Neurogene last reported earnings on August 11, 2026. For this period, the actual earnings per share was -1.53, compared to an estimated earnings per share of -1.4518. The actual revenue reported was $0.00, matching the estimated revenue of $0.00.
Looking at broader analyst sentiment, the current recommendation period starting September 1, 2026, shows a total of 15 recommendations. This includes 6 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell recommendations. This breakdown results in 93.3% positive, 6.7% hold, and 0.0% negative recommendations. These figures are identical to the prior recommendation period starting August 1, 2026, which also recorded 15 total recommendations, consisting of 6 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell ratings, translating to 93.3% positive, 6.7% hold, and 0.0% negative recommendations.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 8, 2026 | JP Morgan | Overweight | initiated coverage |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.